- 優先名称
- Rifamycin B ethylamide
- IUPAC
- [(9E,19E,21E)-27-[2-(ethylamino)-2-oxoethoxy]-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- 現地名
- 4-O-[2-(エチルアミノ)-2-オキソエチル]リファマイシン
- 英語名
- Acetamide, 2-((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12 ,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trieni mino)naphtho(2,1-b)furan-9-yl)oxy)-N-ethyl-, 21-acetate
- 分子式
- C41H54N2O13
- 分子量
- 782.879
名称と別名
Rifamycin B ethylamideNSC14342238327-40-1BRN 5418205NCI 143-422Acetamide, 2-((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-9-yl)oxy)-N-ethyl-, 21-acetate[[2-(ethylamino)-2-oxo-ethoxy]-tetrahydroxy-methoxy-heptamethyl-dioxo-[?]yl] acetateAcetamide, 2-[[(14E)-21-(acetyloxy)-1,2-dihydro-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-9-yl]oxy]-N-ethyl-4-O-[2-(エチルアミノ)-2-オキソエチル]リファマイシンリファマイシンBエチルアミド(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-27-[(エチルカルバモイル)メトキシ]-2,15,17,29-テトラヒドロキシ-11-メトキシ-3,7,12,14,16,18,22-ヘプタメチル-6,23-ジオキソ-8,30-ジオキサ-24-アザテトラシクロ[23.3.1.14,7.05,28]トリアコンタ-1(29),2,4,9,19,21,25,27-オクタエン-13-イル アセタートO4-(ethylcarbamoyl-methyl)-rifamycin
名称をさらに表示
4-O-[2-(Ethylamino)-2-oxoethyl]rifamycinAcetamide, 2-((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12 ,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trieni mino)naphtho(2,1-b)furan-9-yl)oxy)-N-ethyl-, 21-acetate